Gam-COVID-Vac

Viral vector vaccine candidate based on human adenovirus


Gam-COVID-Vac, trade name Sputnik V, is a COVID-19 vaccine candidate developed by the Gamaleya Research Institute of Epidemiology and Microbiology, and registered on 11 August 2020 by the Russian Ministry of Health. Gam-COVID-Vac was approved for distribution in Russia, despite having been tested only in a small number of people in early-stage clinical trials that lasted two months, normally a process requiring a year or more of clinical assessment for proof of vaccine safety and efficacy against viral disease.

Gam-COVID-Vac News and Videos   LIVE

ℹ️ This is a LIVE page which updates automatically as we're monitoring our hand-curated selection of verified and trustworthy media outlets
Indian trials of the Sputnik-V vaccine candidate, being developed by Russia`s sovereign wealth fund, will enroll 1,000-2,000 participants and be conducted at..
Credit: DNA - Published 12 hours ago

Dr Reddy's Laboratories Ltd could begin late-stage Indian clinical trials of Russia's potential coronavirus vaccine in the next few weeks, an executive at the..
Credit: IndiaTimes - Published 14 hours ago

Meanwhile, Russia's sovereign wealth fund on Wednesday agreed to supply 100 million doses of the world's first COVID-19 vaccine Sputnik-V to Indian drug company..
Credit: DNA - Published 6 days ago

Russia’s sovereign wealth fund – Russian Direct Investment Fund (RDIF) — has partnered Hyderabad-based drug maker Dr Reddy’s Laboratories to cooperate on..
Credit: IndiaTimes - Published 6 days ago

Russia's sovereign wealth fund on Wednesday agreed to supply 100 million doses of world's first COVID-19 vaccine Sputnik-V to Indian drug company Dr Reddy's..
Credit: DNA - Published 1 week ago

Russia's sovereign wealth fund said on Wednesday it will supply India's Dr Reddy's Laboratories with 100 million doses of the Sputnik-V vaccine against Covid-19..
Credit: IndiaTimes - Published 1 week ago

You might like